24 results match your criteria: "Montpellier University Hospitals[Affiliation]"
Medicine (Baltimore)
September 2023
Nuclear Medicine Department, Lapeyronie Hospital, Montpellier University Hospitals, Montpellier, France.
Biomedicines
March 2023
Faculty of Medicine, University of Montpellier, PhyMedExp INSERM U1046, 34090 Montpellier, France.
(1) Background: We have previously shown that sputum rheology can discriminate between patients with COPD and other muco-obstructive lung diseases, and that it is correlated with mucin content and sputum eosinophilia. We now hypothesize that it could be a more-accurate guide than clinical evaluation for the prescription of azithromycin to prevent exacerbations of COPD and to reduce exposure to antibiotics; (2) Methods: "COPD CaRhe" is a multicentric, randomized, controlled trial comparing outcomes in two parallel arms (36 vs. 36 patients).
View Article and Find Full Text PDFNPJ Prim Care Respir Med
March 2023
Observational and Pragmatic Research Institute, Midview City, Singapore.
An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short gaps (<90 days) between oral corticosteroid prescriptions sometime during follow-up. The increasing frequency pattern was more likely in patients with greater asthma severity and with more short-acting β-agonist use at baseline. Our approach may provide a clinically relevant representation of intermittent oral corticosteroid use in asthma.
View Article and Find Full Text PDFBiochem Biophys Res Commun
September 2022
Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France; PhyMedExp INSERM U1046, Montpellier, France. Electronic address:
Background: Mucus is known to play a pathogenic role in muco-obstructive lung diseases, but little is known about the determinants of mucus rheology. The purpose of this study is to determine which sputum components influence sputum rheology in patients with muco-obstructive lung diseases.
Methods: We performed a cross sectional prospective cohort study.
Respir Med
January 2022
IMAG, CNRS, University of Montpellier, CHU Montpellier, Montpellier, France. Electronic address:
J Allergy Clin Immunol Pract
April 2021
Observational and Pragmatic Research Institute, Singapore, Singapore; Optimum Patient Care, Cambridge, United Kingdom; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address:
Chest
March 2021
INSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; University of Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France. Electronic address:
Background: Pulmonary venoocclusive disease (PVOD) is an uncommon form of pulmonary hypertension (PH) predominantly characterized by pulmonary vein and capillary involvement. An association between chemotherapy, in particular mitomycin C (MMC), and PVOD has been reported.
Research Question: What are the characteristics of MMC-induced PVOD, and what is the prognosis for patients with MMC-induced PVOD?
Study Design And Methods: We report the clinical, functional, radiologic, and hemodynamic characteristics at diagnosis and outcomes of patients with PVOD from the French PH Registry after exposure to MMC.
BMC Med Res Methodol
August 2020
Optimum Patient Care, Cambridge, UK.
Background: Severe asthma exerts a disproportionately heavy burden on patients and health care. Due to the heterogeneity of the severe asthma population, many patients need to be evaluated to understand the clinical features and outcomes of severe asthma in order to facilitate personalised and targeted care. The International Severe Asthma Registry (ISAR) is a multi-country registry project initiated to aid in this endeavour.
View Article and Find Full Text PDFAm J Obstet Gynecol
July 2020
Obstetrics and Fetal Medicine, Necker-Enfants Malades Hospital, University of Paris, Paris, France. Electronic address:
COVID-19 can severely affect pregnant women Furthermore, issues regarding vertical transmission of severe acute respiratory syndrome coronavirus 2 are emerging. In patients and neonates who are showing symptoms of coronavirus disease 2019, real-time polymerase chain reaction of nasal and throat swabs, sputum, and feces is performed to detect the presence of severe acute respiratory syndrome coronavirus 2. In addition, real-time polymerase chain reaction of vaginal swabs, amniotic fluid, placenta, cord blood, neonatal blood, or breast milk for the detection of severe acute respiratory syndrome coronavirus 2 did not show substantial results.
View Article and Find Full Text PDFClin Exp Allergy
April 2020
AstraZeneca, Gaithersburg, MD, USA.
Background: Oral corticosteroid (OCS) treatment for severe asthma is associated with substantial disease burden. Thus, OCS dosage reduction is desirable. Relative efficacy of biologics in reducing OCS treatment for severe, uncontrolled asthma is not fully characterized.
View Article and Find Full Text PDFPharmaceutics
October 2019
Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France.
Mitotane is the most effective agent in post-operative treatment of adrenocortical carcinoma. In adults, the starting dose is 2-3 g/day and should be slightly increased to reach the therapeutic index of 14-20 mg/L. This study developed a population PK model for mitotane and to simulate recommended/high dosing regimens.
View Article and Find Full Text PDFJ Allergy Clin Immunol
March 2019
IMAG, CNRS, University of Montpellier, CHU Montpellier, Montpellier, France.
Eur Respir J
November 2018
AstraZeneca, Gaithersburg, MD, USA.
Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody that directly depletes eosinophils. Its relative efficacy other IL-5-targeted treatments for patients with severe, uncontrolled asthma is not yet fully characterised.We performed a matching-adjusted indirect comparison (MAIC) of benralizumab mepolizumab and reslizumab.
View Article and Find Full Text PDFDiagn Interv Imaging
May 2018
IMAG, CNRS, université Montpellier, CHU Montpellier, Montpellier, France.
J Allergy Clin Immunol
April 2018
INSERM U 1046, Arnaud de Villeneuve Hospital, Crastes de Paulet Building, Montpellier, France; Department of Medical Information, Montpellier University Hospitals, La Colombière Hospital, Montpellier Cedex, France; Alexander Grothendieck Institut at Montpellier, CNRS, Montpellier University, Montpellier, France.
J Psychosom Res
February 2018
Regional Competency Centre for PAH, CHU Arnaud de Villeneuve, Montpellier, France; Department of Respiratory Diseases, CHU Arnaud de Villeneuve, Montpellier, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier Hospital, Montpellier, France.
Objective: Pulmonary arterial hypertension (PAH) is a rare and life-threatening disease well-marked by under diagnosis, delayed diagnosis and atypical treatments. Few data are available on the quality of life (QoL) and psychosocial characteristics of patients with PAH. Our aim is to describe the impact of psychological factors on the health-related quality of life (HRQoL) of treated PAH patients in a cross-sectional study.
View Article and Find Full Text PDFEur Respir J
November 2017
Assistance Publique - Hôpitaux de Marseille, Clinique des bronches, allergies et sommeil, Hôpital Nord, Marseille, France
Radiology
January 2018
From the Departments of Radiology (M.P.R., I.M., J.B., C.G., T.L., G.C.), Pathology (A.L.), and Thoracic Surgery (L.F.), Cochin Hospital, Paris V University, Sorbonne Paris Cité, 27 rue du Fg St Jacques, Paris 75014, France; Department of Radiology, Pitié Salpétrière Hospital, Paris VI University, Paris, France (P.G.); Center for Visual Computing, Ecole Centrale Paris, Chatenay Malabry, France (G.C.); and Department of Radiology, Arnaud-de-Villeneuve Hospital, Montpellier University Hospitals, Montpellier, France (S.B.).
Purpose To evaluate an objective computed tomographic (CT) criterion for distinguishing between part-solid (PS) and nonsolid (NS) lung nodules. Materials and Methods This study received institutional review board approval, and patients gave informed consent. Preoperative CT studies in all patients who underwent surgery for subsolid nodules between 2008 and 2015 were first reviewed by two senior radiologists, who subjectively classified the nodules as PS or NS.
View Article and Find Full Text PDFTranspl Int
May 2017
Department of Nephrology, Dialysis and Transplantation, Montpellier University Hospitals, University of Montpellier Medical School, Montpellier, France.
Although renal graft percutaneous embolization was introduced to avoid the risk associated with graft nephrectomy, there is no universal consensus about its indications and results. In order to evaluate the efficacy of graft embolization in the treatment of graft intolerance syndrome as well as its safety compared to surgical removal with respect to complications and other morbidity measures, We performed a retrospective observational study comparing two groups of patients treated for graft intolerance syndrome: Group 1: patients who had embolization as first-line treatment and Group 2: patients directly treated by surgical removal. 72 patients were included, (32 in Group 1 and 40 in Group 2); the postintervention follow-up continued for 12 months.
View Article and Find Full Text PDFDiagn Interv Imaging
October 2016
Department of Radiology, Arnaud-de-Villeneuve Hospital, Montpellier University Hospitals, 371, avenue du Doyen-Gaston-Giraud, Montpellier, France.
The major lung resections are the pneumonectomies and lobectomies. The sublobar resections are segmentectomies and wedge resections. These are performed either through open surgery through a thoracotomy or by video-assisted mini-invasive surgery for lobectomies and sublobar resections.
View Article and Find Full Text PDFDiagn Interv Imaging
May 2016
Department of Neuroradiology, Montpellier University Hospitals, Gui-de-Chauliac Hospital, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
Complications of subarachnoid hemorrhage are the major life threatening and functional components of the follow up of a ruptured aneurysm. Knowing how to identify these is a key challenge. They vary in type throughout the postoperative follow up period.
View Article and Find Full Text PDFDiagn Interv Imaging
May 2014
Department of Medical Imaging, Saint-Eloi Hospital, Montpellier University Hospitals, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
We describe the main tools for MR assessment of the response of rectal cancer tumors after chemotherapy, before surgery. In locally advanced cases of rectal and lower rectal cancer, MR is useful in allowing the treatment strategy to be adjusted, enabling conservative surgery to be performed if the patient responds well. The different types of response (fibrous, desmoplastic and colloid), their appearances and difficulties in MR interpretation are described.
View Article and Find Full Text PDFDiagn Interv Imaging
February 2014
Department of Radiology, Lapeyronie Hospital, Montpellier University Hospitals, 34295 Montpellier, France. Electronic address:
The molecular classification of breast cancers defines subgroups of cancer with different prognoses and treatments. Each molecular type representing the intrinsic signature of the cancer corresponds to a histological profile incorporating hormone receptors, HER2 status and the proliferation index. This article describes the correlations between this molecular classification obtained in routine clinical practice using histological parameters and MRI.
View Article and Find Full Text PDFDiagn Interv Imaging
February 2013
Montpellier University Hospitals, Arnaud de Villeneuve Hospital, Medical Imaging, 371, avenue Doyen-Gaston-Giraud, 34295 Montpellier cedex 05, France.
The management of infections in haematology is dictated by the patient's type of acquired or induced immune deficiency (neutropenia, deficiency in cell-mediated or antibody-mediated immunity), and findings from clinical examination, laboratory studies, or morphologic investigations. The CT scan dominates in the initial management and follow-up of these patients, since clinical features very often appear to be non-specific. The radiologist's role is to guide the clinician towards a specific diagnosis such as aspergillosis or pneumocystosis, or to point them towards a non-infectious cause: tumour localisation, hypervolaemia, bronchiolitis obliterans suggestive of GVH disease, drug toxicity, or embolism.
View Article and Find Full Text PDF